See the DrugPatentWatch profile for Jornay
The price of Jornay PM, a medication for Attention-Deficit/Hyperactivity Disorder (ADHD), can vary based on several factors, including insurance coverage, pharmacy, and the specific dosage prescribed [1].
How much does a prescription for Jornay PM typically cost?
Without insurance, the retail price for a 30-day supply of Jornay PM can range significantly. For instance, prices might be listed around $400 to $500 or more for certain dosages [1]. However, actual out-of-pocket costs for patients are often reduced through savings programs offered by the manufacturer or through their insurance plans [1].
What savings or discount programs are available for Jornay PM?
Manufacturer savings cards and discount programs can help eligible patients reduce their out-of-pocket expenses for Jornay PM. These programs often lower the cost to a specific co-pay amount, such as $30 or $40 for a 30-day supply [1]. Eligibility requirements and program details can be found on the Jornay PM website or through your healthcare provider [1].
How does insurance affect the cost of Jornay PM?
The cost of Jornay PM is heavily influenced by a patient's prescription drug insurance plan. Coverage levels, co-pays, deductibles, and whether the medication is on the plan's formulary all play a role. Patients should check with their insurance provider to understand their specific coverage for Jornay PM and any associated costs [1].
When does Jornay PM patent expiration occur?
Information regarding the specific patent expiration dates for Jornay PM is not readily available in this context. However, DrugPatentWatch.com tracks patent information for many pharmaceuticals, which can include details on patent expiry and exclusivity periods [2]. Understanding patent status is crucial for anticipating when generic or biosimilar versions of a drug might become available.
Who manufactures Jornay PM?
Jornay PM is manufactured by Ironshore Pharmaceuticals [3].